Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in ATOS — Atossa Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to ATOS Full portfolio

Position in ATOS

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$752
-$1,262 QoQ
Shares Held
390
+1.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 31 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ATOS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. ATOS ranks #369 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in ATOS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $752 390
2026-03-31 $2,014 383
2025-12-31 $22,459 38,067
2025-09-30 $33,247 38,215
2025-06-30 $2,275 2,741
2025-03-31 $79,680 118,929
2024-12-31 $339,616 361,296
2024-09-30 $227,454 149,642
2024-06-30 $64,257 53,999
2024-03-31 $169 94
2023-12-31 $82 94
2023-09-30 $69 94
2023-06-30 $118 94
2023-03-31 $67 94
2022-12-31 $49 94
2022-09-30 $78 94
2022-06-30 $102 94
2022-03-31 $68,699 54,960
2021-12-31 $69,242 43,277
2021-09-30 $254,520 78,074
2021-06-30 $987,966 156,324